Proceedings (Sep 2019)
(2-Imidazolin-4-yl)phosphonates: Green Chemistry and Biology Walk Together
- Andrea Bagán,
- Sònia Abás,
- Sergio Rodríguez-Arévalo,
- Gemma Rodríguez-Arévalo,
- Fotini Vasilopoulou,
- Christian Griñán-Ferré,
- Mercè Pallàs,
- Pilar Pérez-Lozano,
- Milica Radan,
- Teodora Djikic,
- Katarina Nikolić,
- Carmen Escolano
Affiliations
- Andrea Bagán
- Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine of the University of Barcelona (IBUB), 08028 Barcelona, Spain
- Sònia Abás
- Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine of the University of Barcelona (IBUB), 08028 Barcelona, Spain
- Sergio Rodríguez-Arévalo
- Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine of the University of Barcelona (IBUB), 08028 Barcelona, Spain
- Gemma Rodríguez-Arévalo
- Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine of the University of Barcelona (IBUB), 08028 Barcelona, Spain
- Fotini Vasilopoulou
- Pharmacology Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, 08028 Barcelona, Spain
- Christian Griñán-Ferré
- Pharmacology Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, 08028 Barcelona, Spain
- Mercè Pallàs
- Pharmacology Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, 08028 Barcelona, Spain
- Pilar Pérez-Lozano
- Unit of Pharmaceutical Technology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain
- Milica Radan
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia
- Teodora Djikic
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia
- Katarina Nikolić
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia
- Carmen Escolano
- Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine of the University of Barcelona (IBUB), 08028 Barcelona, Spain
- DOI
- https://doi.org/10.3390/proceedings2019022097
- Journal volume & issue
-
Vol. 22,
no. 1
p. 97
Abstract
2-Imidazoline-containing compounds constitute a valuable class of agents that modulate α2-adrenergic receptors and often show a high affinity for imidazoline I2-receptors (I2-IR). [...]
Keywords
